If you liked this article you might like

Roche Wins FDA Backing for New Multiple Sclerosis Therapy, Competition Could Crimp Biogen
Merck KGaA Shares Spike After FDA Approves Skin Cancer Treatment
Neurotrope Shares Soar as Alzheimer's Drug Trial Lottery Ticket Call Nears
Biotech Stock Mailbag: Puma's Rebound Explained, TG Therapeutics Approval Debate, Aurinia Next Steps